← All diseases Cancer

Non-Hodgkin lymphoma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (62)Meta-analysis (19)Treatment guideline (5)Systematic review (21)Randomized trial (9)Phase 3 study (8)Clinical trial (628)Review article (211)Early study (phase 1 or 2) (53)Case report (387)Laboratory or animal study (21)Commentary or editorial (27) Studies currently seeking participants only (48)

Filter

Publications and studies (2185)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Vallecular Large B-Cell Lymphoma: An Uncommon Presentation of Follicular-Origin Disease. (2026/06/27) ♡
• Marginal zone lymphoma is associated with dysregulated T-cell immunity that is not altered by ibrutinib-venetoclax treatment. (2026/06/25) ♡
• Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma. (2026/06/17) ♡
• Low T3 syndrome in children with aggressive mature B-cell non-Hodgkin lymphoma. (2026/06/15) ♡
• Gastrointestinal toxicity in the treatment of hematological tumors. Influence on nutritional status. (2026/06/15) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Systemic Glucocorticoid Use and Risk of Site-Specific Cancers: A Methodologic Systematic Review of Observational Studies. (2026/06/02) ♡
• Latent Neoehrlichia mikurensis Infections May Be Reactivated in Patients With B-Cell Lymphomas Treated With Rituximab. (2026/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of Primary Refractory Diffuse Large B-Cell Lymphoma in Patients Unsuitable for CAR T-Cell Therapy. (2026/06/01) ♡
• Characterization and cut-off values of skeletal muscle mass in patients with newly diagnosed diffuse large B-cell lymphoma. (2026/06/01) ♡
• Associations of smoking with the risk of second smoking-associated primary cancer among adults with a history of cancer. (2026/06/01) ♡
• [Analysis of the Gene Mutation Distribution and Its Relationship with Prognosis in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma by Next Generation Sequencing]. (2026/06/01) ♡
• Clinical Characteristics and Survival Analysis of Pediatric Non-Hodgkin Lymphoma in Fujian Province. (2026/06/01) ♡
• [The Impact of CD4(+)/CD8(+) Ratio on the Efficacy of CAR-T Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma]. (2026/06/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Clinicopathological Characteristics of Follicular Lymphoma with a Predominantly Diffuse Growth Pattern]. (2026/06/01) ♡
• [Impact of TP53 and MYD88 Mutations on Treatment Efficacy in Diffuse Large B-Cell Lymphoma]. (2026/06/01) ♡
• [Construction of a methionine metabolism-related prognostic signature and the effect of targeting methionine metabolism on diffuse large B-cell lymphoma]. (2026/05/14) ♡
• The global landscape of non-Hodgkin lymphoma incidence and mortality in 2022 and projections to 2045. (2026/05/11) ♡
• Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma. (2026/05/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The New Insight on the Significance of Vascular Endothelial Growth Factor in Anti-angiogenesis Therapy for Diffuse Large B Cell Lymphoma. (2026/05/01) ♡
• Outcome of Non-Hodgkin's Lymphoma in Adults-Real World Experience from a Cancer Centre in North-East India. (2026/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Lytic Lesion of the Scapula Masquerading as Sarcoma: A Rare Manifestation of Diffuse Large B-Cell Lymphoma. (2026/05/01) ♡
• Frequency and Distribution of Lymphomas in Northwestern India: A Retrospective Analysis of 923 Cases Using the Latest World Health Organization Classification 5(th) Edition. (2026/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Non-Hodgkin lymphoma arising in a vallecular cyst: A rare clinical entity. (2026/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Frontline Therapy in Diffuse Large B-Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions. (2026/05/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Dietary fat consumption and cancer outcomes: an umbrella review of systematic reviews and meta-analyses. (2026/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Navigating the Diagnostic Continuum: Feline Lymphoplasmacytic Enteritis and Low-Grade Intestinal T-cell Lymphoma. (2026/05/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Vegetarian and vegan diets and cancer incidence: a systematic review and meta-analysis of prospective studies. (2026/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration. (2026/05/01) ♡
• Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL. (2026/05/01) ♡
• A site-specific risk stratification model for extranodal diffuse large B-cell lymphoma in the oral cavity and maxillofacial region. (2026/04/29) ♡
• Predictors of skeletal muscle loss during first-line therapy in diffuse large B-cell lymphoma: the Glasgow Prognostic Score. (2026/04/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Nontranslocation follicular lymphoma mimicking infectious mononucleosis: a diagnostic challenge in a 39-year-old male. (2026/04/28) ♡
• Serum-free production of anti-huCD20(hγ1)-IL2no-alpha immunocytokine: a promising therapeutic for B-NHL. (2026/04/15) ♡
• Serum free fatty acid promotes tumor progression and predicts golidocitinib sensitivity in peripheral T-cell lymphoma. (2026/04/14) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants. (2026/04/09) ♡
• HIV, HBV, and HCV Testing in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Experience From a Comprehensive Cancer Center. (2026/04/01) ♡
• Outcomes of tisagenlecleucel versus allogeneic hematopoietic stem cell transplantation in relapsed or refractory large B-cell lymphoma. (2026/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based Approaches. (2026/04/01) ♡
• Individualized physical activity program for older adults undergoing chemotherapy for hematologic malignancies. (2026/04/01) ♡
• Vegetarian diets and cancer risk: pooled analysis of 1.8 million women and men in nine prospective studies on three continents. (2026/04/01) ♡
• Small and Large Extracellular Vesicles in Circulation of Diffuse Large B-Cell Lymphoma Patients Originate From Different Cell Types of the Tumor Microenvironment. (2026/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The great masquerader: primary vitreoretinal lymphoma presenting as white dot syndrome. (2026/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnostic and therapeutic challenges in primary vitreoretinal lymphoma: a practical clinical approach. (2026/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery. (2026/03/24) ♡
• Prognostic Role of Absolute Monocyte Count, CD163⁺ Macrophages, and CD8⁺ Lymphocytes in Diffuse Large B-Cell Lymphoma Treated with R-CHOP. (2026/03/12) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Asymptomatic 42-Year-Old Woman With Randomly Distributed Semicalcified Pulmonary Nodules. (2026/03/10) ♡
• The prognostic utility of a combined PNI-HB immunonutritional index in CD19 CAR T-cell therapy for relapsed/refractory non-Hodgkin lymphoma. (2026/03/06) ♡
• Prognostic Value of the CALLY Index in Diffuse Large B-Cell Lymphoma: Linking Inflammation, Nutrition, and Tumor Biology. (2026/03/05) ♡
• Type 2 diabetes and risk of non-Hodgkin lymphoma and multiple myeloma: a pooled analysis. (2026/03/03) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Understanding the factors influencing quality of life among survivors of Non-Hodgkin lymphoma after completing primary treatment: a systematic review. (2026/03/03) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.